Selectively increasing the clearance of protein-bound uremic solutes
Authors:
- 9 January 2012
- journal article
- Published by Oxford University Press (OUP) in Nephrology Dialysis Transplantation
- Vol. 27 (4) , 1574-1579
Abstract
The toxicity of bound solutes could be better evaluated if we could adjust the clearance of such solutes independent of unbound solutes. This study assessed whether bound solute clearances can be increased while maintaining urea clearance constant during the extended hours of nocturnal dialysis. Nine patients on thrice-weekly nocturnal dialysis underwent two experimental dialysis treatments 1 week apart. The experimental treatments were designed to provide the same urea clearance while providing widely different bound solute clearance. One treatment employed a large dialyzer and high dialyzate flow rate (Qd) of 800 mL/min while blood flow (Qb) was 270 mL/min. The other treatment employed a smaller dialyzer and Qd of 300 mL/min while Qb was 350 mL/min. Treatment with the large dialyzer and higher Qd greatly increased the clearances of the bound solutes p-cresol sulfate (PCS: 27±9 versus 14±6 mL/min) and indoxyl sulfate (IS: 26±8 versus 14±5 mL/min) without altering the clearance of urea (204±20 versus 193±16 mL/min). Increasing PCS and IS clearances increased the removal of these solutes (PCS: 375±200 versus 207±86 mg/session; IS: 201±137 versus 153±74 mg/session), while urea removal was not different. The removal of bound solutes can thus be increased by raising the dialyzate flow and dialyzer size above the low levels sufficient to achieve target Kt/V(urea) during extended treatment. Selectively increasing the clearance of bound solutes provides a potential means to test their toxicity.Keywords
This publication has 35 references indexed in Scilit:
- Changing Emphasis in Modern Hemodialysis Therapies: Cost-Effectiveness of Delivering Higher Doses of DialysisThe International Journal of Artificial Organs, 2007
- A Thrice Weekly In-Center Nocturnal Hemodialysis ProgramAdvances in Chronic Kidney Disease, 2007
- P-cresylsulphate, the main in vivo metabolite of p-cresol, activates leucocyte free radical productionNephrology Dialysis Transplantation, 2006
- Clinical Practice Guidelines for Hemodialysis Adequacy, Update 2006American Journal of Kidney Diseases, 2006
- Downloadable computer models for renal replacement therapyKidney International, 2006
- Removal of the protein-bound solute p-cresol by convective transport: A randomized crossover studyAmerican Journal of Kidney Diseases, 2004
- Increasing Dialysate Flow and Dialyzer Mass Transfer Area Coefficient to Increase the Clearance of Protein-bound SolutesJournal of the American Society of Nephrology, 2004
- Daily nocturnal home hemodialysisKidney International, 2004
- Review on uremic toxins: Classification, concentration, and interindividual variabilityKidney International, 2003
- Effect of Dialysis Dose and Membrane Flux in Maintenance HemodialysisNew England Journal of Medicine, 2002